Author: Yoshino S. Ohsawa M.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.336, Iss.2, 1997-10, pp. : 203-209
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Amara Srinivasulu Kumar S. Prasanna Athota Rao R.
Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 37, Iss. 4, 1999-10 ,pp. :
Natalizumab: AN 100226, Anti-4 Integrin Monoclonal Antibody
Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. :
By Sawant Rishikesh Cohen Michael Torchilin Vladimir Rokhlin Oskar
Journal of Drug Targeting, Vol. 16, Iss. 7-8, 2008-08 ,pp. :